TY  - JOUR
AU  - Guijarro, Luis G
AU  - Cano-Martínez, David
AU  - Toledo-Lobo, M Val
AU  - Ruiz-Llorente, Lidia
AU  - Chaparro, María
AU  - Guerra, Iván
AU  - Iborra, Marisa
AU  - Cabriada, José Luis
AU  - Bujanda, Luis
AU  - Taxonera, Carlos
AU  - García-Sánchez, Valle
AU  - Marín-Jiménez, Ignacio
AU  - Barreiro-de Acosta, Manuel
AU  - Vera, Isabel
AU  - Martín-Arranz, María Dolores
AU  - Mesonero, Francisco
AU  - Sempere, Laura
AU  - Gomollón, Fernando
AU  - Hinojosa, Joaquín
AU  - Zoullas, Sofía
AU  - Monserrat, Jorge
AU  - Menor-Salvan, Cesar
AU  - Alvarez-Mon, Melchor
AU  - Gisbert, Javier P
AU  - Ortega, Miguel A
AU  - Hernández-Breijo, Borja
PY  - 2022
DO  - 10.3390/biomedicines10030727
SN  - 2227-9059
UR  - http://hdl.handle.net/10668/20825
T2  - Biomedicines
AB  - Background: Recently, increased tissue levels of AIF-1 have been shown in experimental colitis, supporting its role in intestinal inflammation. Therefore, we studied the levels of AIF-1 in Crohn’s disease (CD). Methods: This study included 33 patients...
LA  - en
KW  - AIF-1
KW  - CRP
KW  - Crohn’s disease
KW  - anti-TNFs
TI  - Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn's Disease Severity.
TY  - research article
VL  - 10
ER  -